Interdisciplinary Care of Pediatric Patients with Chronic Inflammatory Bowel Disease

Interdisciplinary Care of Pediatric Patients with Chronic Inflammatory Bowel Disease - CED-Päd

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017216

Enrollment

Registered

2019-05-10

Start date

2019-05-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inflammatory Bowel Disease

Interventions

Group 1: Needs-oriented, intensified interdisciplinary support Group 2: Control group with routine care

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: - Written consent of the patient (from 14 years) and parents (or the custodian) to participate in the study and the related survey and storage of data - Age of patients is at least 6 years - Chronic inflammatory bowel disease of any form (Morbus Crohn, Colitis Ulcerosa, IBDU- Inflammatory Bowel Disease Unclassified) - Knowledge of the German language required for study participation

Exclusion criteria

Exclusion criteria: - Rejection of participation by the patient or the parents (or the custodian) - Rejection of participation by the treating physician of the study centre - No fulfillment of the other inclusion criteria

Design outcomes

Primary

Measure	Time frame
- Number of drug-related problems in the handling skills of long-term medications and the knowledge about this long-term medication of the respective patient patient after one year - measured by means of a observation form and a questionnaire	—

Secondary

Measure	Time frame
- Change in PUCAI/PCDAI (Pediatric Ulcerative Colitis Activity Index/Pediatric Crohn's Disease Activity Index) depending on disease classification - Change in calprotectin - Increased adherence - Improvement of the quality of life - Number of days absent from school - Attitude towards drug therapy (acceptance) - Patient satisfaction and problems with medication - (Re)hospitalization rate - Number of discrepancies between physician's/parents' assessment on adherence to therapy and the assessment by the patient - Number of prescriptions for drugs to treat chronic inflammatory bowel disease filled at a pharmacy and the time at which the prescription was filled - these routinely documented data are collected after one year from the patient's medical record using a data collection sheet; data on quality of life are assessed by using the KINDL-questionnaire	—

Measure

Time frame

- Change in PUCAI/PCDAI (Pediatric Ulcerative Colitis Activity Index/Pediatric Crohn's Disease Activity Index) depending on disease classification - Change in calprotectin - Increased adherence - Improvement of the quality of life - Number of days absent from school - Attitude towards drug therapy (acceptance) - Patient satisfaction and problems with medication - (Re)hospitalization rate - Number of discrepancies between physician's/parents' assessment on adherence to therapy and the assessment by the patient - Number of prescriptions for drugs to treat chronic inflammatory bowel disease filled at a pharmacy and the time at which the prescription was filled - these routinely documented data are collected after one year from the patient's medical record using a data collection sheet; data on quality of life are assessed by using the KINDL-questionnaire

—

Countries

Germany

Contacts

Public ContactThilo Bertsche

ZAMS - Zentrum für Arzneimittelsicherheit, Universität und Universitätsklinikum Leipzig; Klinische Pharmazie, Institut für Pharmazie, Universität Leipzig

klinische.pharmazie@uni-leipzig.de0341-9736800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026